YPYuanlin Piao

Yuanlin Piao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuanlin Piao has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Dehai Yin

    Department of Traditional Chinese Medicine , Peking Union Medical College Hospital , Beijing , China , pumch.cn

    1 shared publication
  • Guanghua Liu

    Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication
  • Jingmin Zhou

    Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing 100730, P.R. China

    1 shared publication
  • Li Zhao

    Dongzhimen Hospital , Beijing University of Chinese Medicine , Beijing , China , bucm.edu.cn

    1 shared publication
  • Xin Zhao

    Department of Urology, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China

    1 shared publication
  • Xinyuan Liu

    Department of Traditional Chinese Medicine , Peking Union Medical College Hospital , Beijing , China , pumch.cn

    1 shared publication

Latest Publications

  • Open Access

    GSTP1‐Mediated Inhibition of Rac1–Mineralocorticoid Receptor Signaling Underlies the Renoprotective Effect of Huangqi Tujian Decoction in Diabetic Nephropathy

    by Xinyuan Liu, Li Zhao, Dehai Yin, Yuanlin Piao

    Diabetic nephropathy (DN) is a leading cause of end‐stage renal disease, and current therapies often fail to adequately address oxidative stress–induced podocyte injury. Huangqi Tujian Decoction (HTD), a traditional Chinese herbal formula, has shown promise in the clinical management of DN, yet its molecular mechanisms remain incompletely understood. This study aimed to elucidate the protective role of HTD and its interplay with glutathione S‐transferase P1 (GSTP1) and the Rac1–mineralocorticoid receptor (MR) signaling pathway. Integrated bioinformatic analysis of human DN transcriptomes identified GSTP1 as a central hub gene. In vivo studies using db/db mice and streptozotocin‐induced GSTP1‐knockout models revealed that HTD significantly improved renal function; reduced albuminuria, serum creatinine, and blood urea nitrogen levels; and restored podocyte integrity markers (ZO‐1 and Nephrin). HTD treatment also suppressed Rac1–MR activation and downregulated NADPH oxidase subunits, thereby alleviating oxidative stress and apoptosis. Importantly, GSTP1 deficiency completely abolished these protective effects. Coimmunoprecipitation assays demonstrated direct binding between GSTP1 and both Rac1 and MR, suggesting that GSTP1 disrupts the pathogenic Rac1–MR complex. In summary, HTD ameliorates DN by normalizing GSTP1 expression toward physiological levels, thereby disrupting the pathogenic Rac1–MR complex and attenuating oxidative damage and podocyte injury. These findings reveal a novel molecular pathway for HTD and highlight GSTP1 as a promising therapeutic target and potential biomarker for DN.

  • Open Access

    Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis

    by Guanghua Liu, Jingmin Zhou, Yuanlin Piao, Xin Zhao, Yuzhi Zuo, Zhigang Ji

    There is emerging evidence that circular RNAs (circRNAs) act as important regulators in various cancers. It is less clear, however, what role circRNA plays in the tumorigenesis and metastasis of clear cell renal cell carcinoma (ccRCC). In this study, using bioinformatics analysis and a series of experimental analysis, we characterized a novel circRNA, hsa_circ_0085576 was up-regulated in ccRCC tissues and cell lines. High hsa_circ_0085576 expression was significantly correlated with tumor size, clinical stage, and metastasis status and poorer survival. Knockdown of hsa_circ_0085576 notably inhibited cell proliferation, migration, invasion, whereas enhanced cell apoptosis of ccRCC cells, in vitro. In contrast, overexpression of hsa_circ_0085576 had the opposite effects. Moreover, hsa_circ_0085576 silencing significantly suppressed tumor growth and metastasis, whereas overexpression of hsa_circ_0085576 had the opposite effects, in vivo, Our results further showed that hsa_circ_0085576 acted as a competitive endogenous RNAs to interact with microRNA-498, to attenuate its repressive effect on target gene Yes-associated protein 1 (YAP1). Finally, functional studies revealed that inhibition of hsa_circ_0085576 suppressed cell growth and metastasis by regulating miR-498/YAP1 signaling, in ccRCC cells. Based on these findings, hsa_circ_0085576 may represent a valuable prognostic biomarker and a potential therapeutic target to curb the tumorigenesis and metastasis of ccRCC.